Anti-Müllerian hormone — AMH — has become one of the most talked-about markers in discussions of fertility, particularly for women over 35. Understanding what AMH actually measures, what it can and cannot tell you, and how to contextualize results in light of research can help demystify a test that sometimes generates more anxiety than clarity.
AMH is produced by small follicles in the ovaries and is used clinically as a marker of ovarian reserve — broadly, the quantity of remaining eggs. Unlike many hormonal markers, AMH levels are relatively stable throughout the menstrual cycle, making it a convenient test to run at any point. However, what those numbers mean for any individual woman’s fertility and conception prospects is more nuanced than a single value can convey.
What Research Shows About AMH and Age
Research consistently shows that AMH levels decline with age, reflecting the natural, ongoing decrease in the number of follicles in the ovaries. According to studies referenced by the National Institute of Child Health and Human Development, AMH levels typically begin declining more noticeably in the mid-to-late 30s, with significant individual variation in the rate and timing of decline.
This means that two women who are both 37 years old may have quite different AMH levels — and that a lower-than-average AMH doesn’t automatically translate to an inability to conceive, nor does a higher-than-average AMH guarantee easy conception. AMH tells us about the quantity side of the egg equation; it doesn’t directly measure egg quality, which is another important factor in fertility.
What AMH Testing Can and Cannot Tell You
AMH testing has genuine clinical utility, particularly in the context of fertility treatment planning. For women undergoing IVF, AMH levels help predict how many eggs a woman might produce in response to ovarian stimulation — which in turn affects protocol design and realistic expectations for egg retrieval.
What AMH testing is less well-suited for is predicting natural conception chances for an individual woman, or serving as a simple fertility report card. Research shows that women with low AMH for their age can and do conceive naturally, and women with normal AMH can experience infertility for other reasons entirely. A low AMH result in a woman trying to conceive naturally should prompt a conversation with a healthcare provider — not an assumption that conception is impossible.
AMH and Contraceptive Decisions
Some women use AMH testing as a tool for family planning timing decisions, reasoning that a low AMH might indicate urgency. This is an area where research caution is warranted: current evidence doesn’t support using AMH testing to guide contraceptive decisions in women who aren’t actively trying to conceive, as the predictive value for natural conception timing at a population level is limited. If you’re considering AMH testing for planning purposes, discussing what the results could and couldn’t realistically tell you with a reproductive specialist first is advisable.
Understanding AMH Results in Context
AMH reference ranges vary between laboratories, and what constitutes “low,” “normal,” or “high” is not uniformly defined across clinical settings. Results are typically considered in the context of:
- Age: What’s expected varies considerably by age, so a number that looks low in absolute terms may be appropriate for a woman’s age cohort.
- Clinical goals: Whether a woman is pursuing IVF, IUI, or natural conception affects how AMH results are interpreted and acted upon.
- Other fertility markers: AMH is one piece of a fertility evaluation that may also include antral follicle count (AFC), FSH levels, estradiol, and uterine assessment.
For women over 35 who are navigating the process of trying to conceive, receiving AMH results in isolation — without clinical context — can feel alarming or confusing. A reproductive endocrinologist is the most appropriate professional to interpret AMH results within a complete fertility evaluation.
Factors That May Affect AMH Levels
Beyond age, research has identified several factors that may influence AMH levels to varying degrees:
- Prior ovarian surgery: Procedures on the ovaries — including those for endometrioma or ovarian cysts — may reduce AMH by affecting follicle-containing tissue.
- Contraceptive hormones: Hormonal contraceptives, particularly combined oral contraceptives, appear to transiently suppress AMH levels in some research, though AMH typically recovers after discontinuation.
- Body composition: Some studies suggest associations between BMI and AMH, though the relationship is complex.
- Vitamin D status: Some research has found associations between vitamin D levels and AMH, though causal relationships remain unclear.
If Your AMH Is Lower Than Expected
A lower-than-expected AMH for your age is not a verdict. It’s information — one piece of a larger picture. Many women with low ovarian reserve have successfully conceived, either naturally or with assisted reproductive technologies. What a lower AMH level may suggest is that there’s value in seeking evaluation and, if fertility is a goal, potentially doing so sooner rather than later — so that options can be discussed before the window narrows further.
A reproductive endocrinologist can help you understand what a specific result means for your individual situation, what additional evaluation might be helpful, and what options may be most appropriate given your full health and fertility picture. This kind of personalized guidance is far more useful than general anxiety about a number. For broader support through the emotional dimensions of fertility challenges, connecting with appropriate mental health and peer support resources can also be valuable.
Frequently Asked Questions
Can I increase my AMH levels naturally?
Research on interventions to raise AMH levels is limited and largely inconclusive. Some small studies have explored vitamin D supplementation and other nutritional factors, but there is no established intervention that reliably increases ovarian reserve. The underlying decline in follicle number that AMH reflects is a biological process that current science cannot reverse. Focusing on overall health and seeking timely clinical evaluation is more evidence-based than pursuing unproven supplements.
When is AMH testing typically recommended?
AMH testing is most commonly used when a woman is undergoing or considering fertility evaluation, particularly before IVF. It may also be discussed as part of a basic fertility workup for women over 35 who have been trying to conceive for six months or more without success, as recommended by ACOG. Testing is also sometimes offered to women with conditions that may affect ovarian reserve, such as endometriosis or a history of ovarian surgery.
Is AMH the most important fertility marker?
No single marker tells the complete fertility story. AMH is a useful indicator of ovarian reserve (quantity), but egg quality — which is also highly relevant to fertility and pregnancy outcomes — is not directly measured by AMH. Other factors including uterine health, fallopian tube patency, partner fertility, and overall health all matter. A comprehensive fertility evaluation considers multiple dimensions rather than focusing on any single test.
Key Takeaways
- AMH is a marker of ovarian reserve (egg quantity) that declines with age, with significant individual variation in the timing and degree of decline.
- A lower AMH does not mean conception is impossible; many women with lower-than-average AMH conceive naturally or with assisted reproduction.
- AMH is most clinically useful in the context of fertility treatment planning, particularly IVF, and is less reliable as a standalone predictor of natural conception chances.
- AMH results are best interpreted by a reproductive endocrinologist in the context of a complete fertility evaluation, not in isolation.
- If you have concerns about ovarian reserve, seeking early evaluation with a specialist provides the most individualized and actionable information.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.